| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/27/1996 | US5494816 Enhanced indole biosynthesis |
| 02/27/1996 | US5494812 Culture product of streptomyces |
| 02/27/1996 | US5494809 Culturing and incubating cells of bacillus amyloliquefaciens |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/27/1996 | US5494805 Comprising test organism and two redox indicators in an agar medium, observing color change |
| 02/27/1996 | US5494792 Kainate-binding, human CNS receptors of the EAA2 family |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/27/1996 | US5494664 Bifidobacteria |
| 02/27/1996 | CA1338085C Antibiotics bu-3608d and bu-3608e from actinomadura |
| 02/22/1996 | WO1996005353A1 A method for desizing cellulose-containing fabric |
| 02/22/1996 | WO1996005318A1 Mutated penicillin g acylase genes |
| 02/22/1996 | WO1996005314A2 Protein toxins active against lepidopteran pests |
| 02/22/1996 | WO1996005301A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | WO1996005295A2 An improved cleaning composition |
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005226A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004925A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 02/22/1996 | DE19503359C1 Plants with increased tolerance towards stress |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2197203A1 An improved cleaning composition |
| 02/22/1996 | CA2196080A1 Protein toxins active against lepidopteran pests |
| 02/21/1996 | EP0697462A2 Process for producing Glycine-N-Methyl Transferase using recombinant DNA |
| 02/21/1996 | EP0697461A1 Recombinant thermostable enzyme which releases trehalose from non-reducing saccharide |
| 02/21/1996 | EP0697170A1 Coated pesticidal agents, processes for their preparation and compositions containing them |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492830 Enzymatic resolution of α-tertiary carboxylic acid esters |
| 02/20/1996 | US5492824 Interleukins |
| 02/20/1996 | US5492823 Method for direct cloning and producing the BsoBI restriction endonuclease in E. coli |
| 02/20/1996 | US5492818 Method of producing L-glutamic acid by fermentation |
| 02/20/1996 | US5492813 Muteins of β-galactosidase fragments having increased activity |
| 02/20/1996 | CA2155134A1 Branched polysaccharide, microorganism producing it and compositions containing them |
| 02/20/1996 | CA2107110C Novel immunosuppressant agent from streptomyces braegensis |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004377A1 Production of tissue factor pathway inhibitor |
| 02/15/1996 | WO1996004364A1 Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996003997A2 Treatment of cancer using hsv mutant |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1995021250A3 Production of pharmaceutical-grade plasmid dna |
| 02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696638A1 Process for lysing mycobacteria |
| 02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
| 02/14/1996 | EP0696324A1 Integrative dna segment comprising gene encoding insecticidal protein |
| 02/14/1996 | EP0696323A1 Recombinant alanine racemase and gapdh from tolypocladium |
| 02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 02/14/1996 | EP0696317A1 HUMAN $i(SYK) |
| 02/14/1996 | EP0696316A1 Viable bacteria |
| 02/14/1996 | EP0696198A1 Novel polypeptide having factor xa inhibitory activity |
| 02/14/1996 | EP0487557B1 Improvement of pulp bleaching |
| 02/14/1996 | EP0205579B1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| 02/14/1996 | CN1116655A Process for gene tranfer into plant cells |
| 02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/13/1996 | US5491167 Inhibitors of cholesterol biosynthesis |
| 02/13/1996 | US5491122 Metabolites of a culture product |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491086 Heat resistant enzyme proteins as vectors for genetic engineering |
| 02/13/1996 | US5491079 Promoterless foreign gene integrated in Streptococcus thermophilus |
| 02/13/1996 | US5491077 Stereoselective reduction of phenyl alkyl ketone to alcohol using microbacterium strains |
| 02/13/1996 | US5491068 Capture of specific bacterial cells with specific antibodies immobilized on magnetic beads, incubation of cells by beads to form bacterial colony, imprint colonies to a colony lift membrane, quantification and confirmation of colonies |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003521A1 Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003518A1 Process for demethylating s-methyl-mercapto compounds |
| 02/08/1996 | WO1996003516A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003514A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | WO1996003513A2 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003498A1 Purified herpes simplex virus protease and methods of purification |
| 02/08/1996 | WO1996003494A1 Method of control of microorganism growth process |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003433A1 New process for the production of biologically active protein |
| 02/08/1996 | WO1996003430A1 Organic compounds |